Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
138,140,158
-
Share change
-
-8,723,649
-
Total reported value
-
$694,939,041
-
Put/Call ratio
-
44%
-
Price per share
-
$5.03
-
Number of holders
-
202
-
Value change
-
-$49,522,483
-
Number of buys
-
102
-
Number of sells
-
91
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q3 2015
As of 30 Sep 2015,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
138,140,158 shares.
The largest 10 holders included
FIRST TRUST ADVISORS LP, BlackRock Fund Advisors, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Gotham Asset Management, LLC, Invesco Ltd., Advisors Asset Management, Inc., BlackRock Institutional Trust Company, N.A., ACADIAN ASSET MANAGEMENT LLC, and STATE STREET CORP.
This page lists
202
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.